Transcription of The Diagnosis and Management of Nonalcoholic Fatty Liver ...
{{id}} {{{paragraph}}}
The Diagnosis and Management ofNonalcoholic Fatty Liver Disease:Practice Guidance From the AmericanAssociation for the Study ofLiver DiseasesNaga Chalasani,1 Zobair Younossi,2 Joel E. Lavine,3 Michael Charlton,4 Kenneth Cusi,5 Mary Rinella,6 Stephen A. Harrison,7 Elizabeth M. Brunt,8and Arun J. Sanyal9 PreambleThis guidance provides a data-supported approach tothe diagnostic, therapeutic, and preventive aspects ofnonalcoholic Fatty Liver disease (NAFLD) care. A Guidance document is different from a Guideline. Guidelinesare developed by a multidisciplinary panel ofexperts and rate the quality (level) of the evidence andthe strength of each recommendation using the GradingAbbreviations: AASLD, American Association for the Study of Liver Diseases; ACG, American College of Gastroenterology; AIH, autoimmune hepa-titis; ALT, alanine aminotransferase; APRI, AST to platelet ratio index; AST, aspartate aminotransferase; AUROC, area under the receiver operatingcurve; BMI, body mass index; CI, confidence interval; CLD, chronic Liver disease; CT, computed tomography; CVD, car
Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases Naga Chalasani,1 Zobair Younossi ,2 Joel E. Lavine,3 Michael Charlton,4 Kenneth Cusi,5 Mary Rinella,6 Stephen A. Harrison,7 Elizabeth M. Brunt,8 and Arun J. Sanyal9 Preamble This guidance provides a data-supported approach to
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}